Cargando…
HPV-Related Promoter Methylation-Based Gene Signature Predicts Clinical Prognosis of Patients With Cervical Cancer
Persistent high-risk HPV infection drives tumorigenesis in various human malignancies, including cervical, oropharyngeal, anal, and vulvar carcinomas. Although HPV-related tumors arise in several different sites, they share many common genetic and epigenetic events. Complex and heterogeneous genomic...
Autores principales: | Zhou, Ran, Chen, Zhuo, Xiao, Zuo-Run, Wang, Shou-Li, Rong, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566918/ https://www.ncbi.nlm.nih.gov/pubmed/34745985 http://dx.doi.org/10.3389/fonc.2021.753102 |
Ejemplares similares
-
Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023) -
Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer
por: Contreras-Romero, Carlos, et al.
Publicado: (2022) -
Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer
por: Li, Lincheng, et al.
Publicado: (2022) -
Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022) -
High RPS27A Expression Predicts Poor Prognosis in Patients With HPV Type 16 Cervical Cancer
por: Wang, Qiming, et al.
Publicado: (2021)